Get the Stockscreener App
12.77
11.44%
-1.65
After Hours:
12.63
-0.14
-1.10%
Instil Bio Inc stock is traded at $12.77, with a volume of 199.91K.
It is down -11.44% in the last 24 hours and down -33.09% over the past month.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
See More
Previous Close:
$14.42
Open:
$14.5
24h Volume:
199.91K
Relative Volume:
1.65
Market Cap:
$97.35M
Revenue:
-
Net Income/Loss:
$-74.14M
P/E Ratio:
-1.1212
EPS:
-11.39
Net Cash Flow:
$-65.70M
1W Performance:
-13.77%
1M Performance:
-33.09%
6M Performance:
-12.71%
1Y Performance:
-51.81%
1-Day Range:
$12.28
$14.54
1-Week Range:
$12.28
$16.00
52-Week Range:
$10.80
$42.79
Instil Bio Inc Stock (TIL) Company Profile
Name
Instil Bio Inc
Sector
Industry
Phone
(972) 499-3350
Address
3963 MAPLE AVENUE, DALLAS
Compare TIL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TIL
Instil Bio Inc
|
12.77 | 97.35M | 0 | -74.14M | -65.70M | -11.39 |
|
ARGX
Argen X Se Adr
|
929.61 | 55.90B | 3.06B | 1.28B | 447.35M | 19.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
434.02 | 110.91B | 11.74B | 3.68B | 3.34B | 14.19 |
|
INSM
Insmed Inc
|
197.40 | 41.21B | 447.02M | -1.18B | -906.14M | -6.1812 |
|
ONC
Beone Medicines Ltd Adr
|
376.63 | 40.48B | 4.98B | 69.59M | 525.67M | 0.5197 |
|
REGN
Regeneron Pharmaceuticals Inc
|
704.31 | 72.89B | 14.25B | 4.58B | 3.88B | 41.77 |
Instil Bio Inc Stock (TIL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-07-25 | Upgrade | Jefferies | Hold → Buy |
| Nov-04-24 | Initiated | JMP Securities | Mkt Perform |
| Apr-12-24 | Downgrade | Jefferies | Buy → Hold |
| Nov-01-22 | Downgrade | Cowen | Outperform → Market Perform |
| Nov-01-22 | Downgrade | Truist | Buy → Hold |
| Aug-13-21 | Initiated | Robert W. Baird | Outperform |
| Apr-13-21 | Initiated | Cowen | Outperform |
| Apr-13-21 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-13-21 | Initiated | Truist | Buy |
View All
Instil Bio Inc Stock (TIL) Latest News
What to expect from Instil Bio Inc. in the next 30 daysJuly 2025 Update & Short-Term Swing Trade Alerts - newser.com
Signal strength of Instil Bio Inc. stock in tech scannersStop Loss & Stock Portfolio Risk Control - newser.com
Applying Wyckoff theory to Instil Bio Inc. stockQuarterly Profit Report & Reliable Intraday Trade Alerts - newser.com
Published on: 2025-11-16 10:13:27 - newser.com
Applying big data sentiment scoring on Instil Bio Inc.July 2025 Fed Impact & Daily Chart Pattern Signal Reports - newser.com
Will Instil Bio Inc. stock benefit from automationIPO Watch & Advanced Swing Trade Entry Plans - newser.com
Will Instil Bio Inc. stock maintain momentum in 20252025 Bull vs Bear & Consistent Return Investment Signals - newser.com
Is Instil Bio Inc. stock attractive for long term wealth buildingWall Street Watch & Low Drawdown Investment Ideas - newser.com
What hedge fund activity signals for Instil Bio Inc. stockAnalyst Upgrade & Low Drawdown Investment Strategies - newser.com
Heatmap analysis for Instil Bio Inc. and competitors2025 AllTime Highs & Accurate Entry/Exit Alerts - newser.com
Can Instil Bio Inc. stock maintain growth trajectoryJuly 2025 WrapUp & Free Daily Entry Point Trade Alerts - newser.com
Evaluating Instil Bio Inc. with trendline analysisQuarterly Portfolio Summary & Reliable Intraday Trade Plans - newser.com
Can Instil Bio Inc. stock deliver consistent earnings growth2025 Top Gainers & Daily Volume Surge Signals - newser.com
Instil Bio Narrows Losses And Impresses Wall Street Analysts - Finimize
Instil Bio Inc Stock Analysis and ForecastInsider Selling Patterns & Trade Like a Pro Using AI Edge - earlytimes.in
Instil Bio Reports Third Quarter 2025 Financial Results and Provides Corporate Update - The Manila Times
Instil Bio, Inc. SEC 10-Q Report - TradingView
Instil Bio Q3 net loss per share narrows - MarketScreener
Published on: 2025-11-13 02:01:06 - newser.com
How Instil Bio Inc. stock reacts to job market dataMarket Risk Report & Long-Term Growth Stock Strategies - newser.com
The Technical Signals Behind (TIL) That Institutions Follow - news.stocktradersdaily.com
Instil Bio Inc Stock (TIL) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.99%
1.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):